WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC)

Tumor Biology

Volumn 31, Issue 4, 2010, Pages 315-320

  Baykara, Onur ^a   Demirkaya, Ahmet ^a   Kaynak, Kamil ^a   Tanju, Serhan ^b   Toker, Alper ^b   Buyru, Nur ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Lung cancer; Mutation screening; NSCLC; Promoter hypermethylation; WWOX

Indexed keywords

ADENINE; ALANINE; ARGININE; CYTIDINE; CYTOSINE; GENOMIC DNA; GUANIDINE; PROLINE; THREONINE; THYMIDINE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WW DOMAIN CONTAINING OXIDOREDUCTASE; DNA; OXIDOREDUCTASE; WWOX PROTEIN, HUMAN;

AGE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA POLYMORPHISM; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; GERMLINE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; BLOOD; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MUTATION; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; OXIDOREDUCTASES; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 77954647657     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-010-0039-3     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, Pisami P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. La Vecchia C, Franceschi S, Levi F. Epidemiological research on cancer with a focus on Europe. Eur J Cancer Prev. 2003;12:5-14.
3. Peto R, Darby S, Deo H. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321:323-9.
4. Simonato L, Agudo A, Ahrens W. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogenity. Int J Cancer. 2001;91:876-87.
5. Capewell S, Sankaran R, Lamb D. Lung cancer in lifelong nonsmokers. Edinburgh Lung Cancer Group. Thorax. 1991;46:565-8.
6. Yunis JJ, Sarens AL, Bowe AE. Fragile sites are targets of diverse mutagens and carcinogens. Oncogene. 1987;1:59-69.
7. Bednarek AK, Laflin KJ, Daniel RL, et al. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 2000;60:2140-5.
8. Ludes-Meyers JH, Bednarek AK, Popescu NC, et al. WWOX, the common chromosomal fragile site, FRA16D, cancer gene. Cytogenet Genome Res. 2003;100:101-10.
9. Ludes-Meyers JH, Kil H, Bednarek AK, et al. WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins. Oncogene. 2004;23:5049-55.
10. Aqeilan RI, Pekarsky Y, Herrero JJ, et al. Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci. 2004;101:4401-6.
11. Aqeilan RI, Palamarchuk A, Weigel RJ, et al. Physical and functional interactions between the WWOX tumor suppressor protein and the AP-2? transcription factor. Cancer Res. 2004;64:8256-61.
12. Aqeilan RI, Donati V, Palamarchuk A, et al. WW-domain containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res. 2005;65:6764-72.
13. Hezova R, Ehrmann J, Kolar Z. WWOX, a new potential tumor supressor gene. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007;151(1):11-5.
14. Chang N-S, Doherty J, Ensign A. JNK1 physically interacts with WW-domain containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis. J Biol Chem. 2003;278:9195-202.
15. Wang X, Chao L, Jin G, et al. Association between CpG island methylation of the WWOX gene and its expression in breast cancers. Tumor Biol. 2009;30:8-14.
16. Alsop AE, Taylor K, Zhang J, et al. Homozygous deletions may be markers of nearby heterozygous mutations.: the complex deletion at FRA16D in the colon cancer cell line removes exons of WWOX genes. Chromosomes & cancer. 2008;47:437-47.
17. Aqeilan RI, Trapasso F, Hussain S, et al. Targeted deletions of WWOX reveals a tumor suppressor function. Proc Nat Acad Sci. 2007;104:3949-54.
18. Wang M, Gu J, Wang Y, et al. Loss of WWOX expression in human extrahepatic cholangiocarcinoma. J Cancer Res Clin Oncol. 2008;135(1):39-44.
19. Kuroki T, Trapasso F, Shiraishi T, et al. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res. 2002;62:2258-60.
20. Herman JG, Graff JR, Myöhanen S, et al. Methylation-specific PCR: a novel PCR assay for metylation status of CpG islands. Proc Natl Acad Sci USA. 1996;93:9821-6.
21. Yendamuri S, Kuroki T, Trapasso F, et al. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res. 2003;63:878-81.
22. Donati V, Fontanini G, Dell'Omodarme M, et al. WWOX expression in different histological types and subtypes of nonsmall cell lung cancer. Clin Cancer Res. 2007;13:884-91.
23. Paige AJ, Taylor KJ, Taylor C, et al. WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci USA. 2001;98:11417-22.
24. Pimenta F, Gomes DA, Perdigao PF, et al. Characterization of the tumor supressor gene WWOX in primary human oral squamous cell carcinomas. Int J Cancer. 2006;118:1154-8.
25. Kuroki T, Yendamuri S, Trapasso F, et al. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res. 2004;10:2459-65.
26. Iliopoulos D, Guler G, Han SY, et al. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene. 2005;24:1625-33.